Intensity-modulated radiotherapy for head and neck cancer

Clinical Advances in Hematology and Oncology

Volumn 5, Issue 6, 2007, Pages 425-431

  Caglar, Hale B ^a   Allen, Aaron M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Head and neck; IMRT; Radiation therapy

Indexed keywords

ANTINEOPLASTIC AGENT;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER CONTROL; CANCER RECURRENCE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED DRUG THERAPY; DYSPHAGIA; EYE; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; INTERMETHOD COMPARISON; METASTASIS; NASOPHARYNX CANCER; OROPHARYNX CARCINOMA; PARANASAL SINUS CARCINOMA; PAROTID GLAND; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RADIATION INJURY; RADIATION NECROSIS; RADIATION SAFETY; SALIVARY GLAND FUNCTION; SPINE; TARGET ORGAN; XEROSTOMIA;

CARCINOMA, SQUAMOUS CELL; CLINICAL TRIALS; HEAD AND NECK NEOPLASMS; PAROTID GLAND; RADIATION INJURIES; RADIOTHERAPY, INTENSITY-MODULATED;

EID: 34447260034     PISSN: 15430790     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. American Cancer Society, Inc: Surveillance Research, report, 2004.
2. Intensity Modulated Radiation Therapy Collaborative Working Group. Intensity-modulated radiotherapy: current status and issues of interest. Int J Rad Oncol Biol Phys. 2001;51:880-914.
3. Chui CS, Spirou SV. Inverse planning algorithms for external beam radiation therapy. Med Dosimetry. 2001;26:189-197.
4. Leibel SA, Fuks Z, Zelefsky MJ, et al. Technological advances in external-beam radiation therapy for the treatment of localized prostate cancer. Semin Oncol. 2003; 30:596-615.
5. Chui CS, Chan MF, Yorke E, Spirou S, Ling CC. Delivery of intensity-modulated radiation therapy with a conventional multileaf collimator: comparison of dynamic and segmental methods. Med Phys. 2001;28:2441-2449.
6. Nutting C. Intensity-modulated radiotherapy (IMRT): the most important advance in radiotherapy since the linear accelerator? Br J Radiol. 2003;76:673.
7. Chao KS, Ozyigit G, Tran BN, et al. Patterns of failure in patients receiving definitive and postoperative IMRT for head and neck cancer. Int J Radiat Oncol Biol Phys. 2003;55:312-321.
8. Lee N, Xia P, Fischbein NJ, Akazawa P, Akazawa C, Quivey JM. Intensity-modulated radiation therapy for head and neck cancer: the UCSF experience focusing on target volume delineation. Int J Radiat Oncol Biol Phys. 2003;57:49-60.
9. Marks JE, Bedwinek JM, Lee F, et al. Dose-response analysis for nasopharyngeal carcinoma. Cancer 1982;50:1042-1050.
10. Xia P, Fu KK, Wong GW, et al. Comparison of treatment plans involving intensity modulated radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2000;48;329-337.
11. Wolden SL, Zelefsky MJ, Hunt MA, et al. Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2001;49:1229-1234.
12. Hunt MA, Zelefsky MJ, Wolden S, et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys. 2001;49:623-632.
13. Kam MK, Chau RM, Suen J, Choi PH, Teo PM. Intensity-modulated radio-therapy in nasopharyngeal carcinoma: dosimetric advantage over conventional plans and feasibility of dose escalation. Int J Radiat Oncol Biol Phys. 2003;56: 145-157.
14. Kam MK, Leung SF, Zee B, et al. Impact of intensity-modulated radiotherapy (IMRT) on salivary gland function in early-stage nasopharyngeal carcinoma (NPC) patients: a prospective randomized study. ASCO Annual Meeting Proceedings 2005; Abstract 5501.
15. Lee N, Xia P, Quivey JM, et al. Intensity-modulated radiotherapy in the treatment of nasopharyngeal carcinoma: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2002;53:12-22.
16. Bucci M, XIa P, Lee N, et al. Intensity modulated radiation therapy for carcinoma of the nasopharynx: an update of the UCSF experience. Int J Radiat Oncol Biol Phys. 2004;60:S317-S318.
17. Kwong DL, Pow EH, Sham JS, et al. Intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: a prospective study on disease control and preservation of salivary function. Cancer. 2004;101:1584-1593.
18. Kam MK, Teo PM, Chau RM, et al. Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: the Hong Kong experience. Int J Radiat Oncol Biol Phys. 2004;60:1440-1450.
19. Wolden SL, Chen Wc, Pfister DG, et al. Intensity-modulated radiation therapy (IMRT) for nasopharynx cancer: update of the Memorial Sloan-Kettering experience. Int J Radiat Oncol Biol Phys. 2006;64:57-62.
20. Calais G, Alfonsi M, Bardet E, et al. Randomized trial of radiation therapy versus concomitant chemotherapy and radiation therapy for advanced-staged oropharynx carcinoma. J Nad Cancer Inst. 1999;91:2081-2086.
21. Calais G, Alfonsi M, Bardet E, et al. Stage III and IV cancers of the oropharynx: results of a randomized study of GORTEC comparing radiotherapy alone with concomitant chemotherapy. Bull Cancer. 2000;87:48-53.
22. Denis F, Garaud P, Bardet E, et al. Final results of the 94-01 French Head and Neck Oncology and Radiotherapy Group randomized trial comparing radio-therapy alone with concomitant radiochemotherapy in advanced-stage oropharynx carcinoma. J Clin Oncol. 2004;22:69-76.
23. Fu KK, Pajak TF, Trotti A, et al. A Radiation Therapy Oncology Group (RTOG) phase III randomized study to compare hyperfractionation and two variants of accelerated fractionation to standard fractionation radiotherapy for head and neck squamous cell carcinomas: first report of RTOG 9003. Int J Radiat Oncol Biol Phys. 2000;48:7-16.
24. Hilhnan JD. Principles of microbial ecology and their application to xero-stomia-associated opportunistic infections of the oral cavity. Adv Dent Res. 1996; 10:66-68.
25. Ramirez-Amador V, Silverman S Jr, Mayer P, Tyler M, Quivey J. Candidal colonization and oral candidiasis in patients undergoing oral and pharyngeal radiation therapy. Oral Surg Oral Med Oral Patho Oral Radiol Endod. 1997;84: 149-153.
26. Lin A, Kim HM, Terrell JE, Dawson LA, Ship JA, Eisbruch A. Quality of life after parotid-sparing IMRT for head and neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys. 2003;57:61-70.
27. Eisbruch A, Ship JA, Dawson LA, et al. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer, World J Surg. 2003; 27:832-837.
28. Eisbruch A, Kim HM, Terrell JE, Marsh LH, Dawson LA, Ship JA. Xero-stomia and its predictors following parotid-sparing irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys. 2001;50:695-704.
29. Chao KS, Ozyigit G, Blanco AI, et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume, Int J Radiat Oncol Biol Phys. 2004;59:43-50
30. Chao KS, Deasy JO, Markman J, et al. A prospective study of salivary function sparing in patients with head and neck cancers receiving intensity-modulated or three-dimensional radiation therapy: initial results. Int J Radiat Oncol Biol Phys. 2001;49:907-916.
31. Parliament MB, Scrimger RA, Anderson SG, et al. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity-modulated radiotherapy (IMRT) for head and neck cancer. Int J Radiat Oncol Biol Phys. 2004;58:663-673.
32. Eisbruch A, Ten Haken RK, Kim HM, et al. Dose, volume and functional relationship in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Oncol Biol Phys. 1999;45:577-587.
33. Chao KSC, Majhaila N, Huanga C et al. Intensity-modulated radiation therapy reduces late salivary toxicity without compromising tumor control in patients with oropharyngeal carcinoma: a comparison with conventional techniques. Radiother Oncol. 2001;61:275-280.
34. Eisbruch A, Marsh LH, Dawson LA, et al. Recurrences near base of skull after IMRT for head and neck cancer: implications for target delineation in high neck and for parotid gland sparing. Int J Radiat Oncol Biol Phys. 2004;59:28-42.
35. Huang K, Lee N, Xia R Intensity-modulated radiotherapy in the treatment of oropharyngeal carcinoma: a single institutional experience. Int J Radiat Oncol Biol Phys. 2003;57:S302.
36. De Arruda FF, Puri DR, Zhung J, et al. Intensity-modulated radiation therapy for the treatment of oropharyngeal carcinoma: the Memorial Sloan-Kettering Cancer Center experience. Int J Radiat Oncol Biol Phys. 2006;64:363-373.
37. Yao MY, Nyugen T, Buatti JM, et al. Changing failure patterns in oropharyngeal squamous cell carcinoma treated with intensity modulated radiotherapy and implications for future research. Am J Clin Oncol. 2006;29:606-612.
38. Garden AS, Morrison W, Rosenthal D, et al. Intensity modulated radiation therapy (IMRT) for metastatic cervical adenopathy from oropharynx carcinoma. Int J Radiat Oncol Biol Phys. 2003;57:S302.
39. Shukovsky LJ, Fletcher GH: Retinal and optic nerve complications in a high dose irradiation technique of ethmoid sinus and nasal cavity. Radiology. 1972;104:629-634.
40. Ellingwood KE, Million RR: Cancer of the nasal cavity and ethmoid/ sphenoid sinuses. Cancer. 1979;43:1517-1526.
41. Katz TS, Mendenhall WM, Morris CG, Amdur RJ, Hinerman RW, Villaret DB: Malignant tumors of the nasal cavity and paranasal sinuses. Head Neck. 2002, 24:821-829.
42. Claus F. De Gersem W, De Wagrer C, et al. An implementation strategy for IMRT of ethmoid sinus cancer with bilateral sparing of the optic pathway. Int J Radiat Oncol Biol Phys. 2001;51:318-331.
43. Adams E, Nutting C, Convery D, et al. The potential role of intensity-modulated radiotherapy in the treatment of tumors of the maxillary sinus, Int J Radiat Oncol Biol Phys. 2001;51:579-588.
44. Tsien C, Eisbruch A, McShan D, et al. Intensity-modulated radiation therapy (IMRT) for locally advanced paranasal sinus tumors: Incorporating clinically decisions in the optimization process. Int J Radiat Oncol Biol Phys. 2001;55:776-784.
45. Huang D, Xia P, Akazawa P, et al. Comparison of treatment plans using intensity-modulated radiotherapy and three-dimensional conformal radiotherapy for paranasal sinus carcinoma, Int J Radiat Oncol Biol Phys. 2003;56:158-168.
46. Mock U, Georg D, Bogner J, Auberger T, Potter R. Treatment planning comparison of conventional, 3D conformal, and intensity-modulated photon (IMRT) and proton therapy for paranasal sinus carcinoma, Int J Radiat Oncol Biol Phys. 2004;58:147-154.
47. Duthoy W, Boterberg T, Claus F, et al. Postoperative intensity-modulated radiotherapy in sinonasal carcinoma: clinical results in 39 patients. Cancer. 2005;104:71-82.
48. Combs SE, Konkel S, Schulz-Ertner D, et al. Intensity modulated radiotherapy (IMRT) in patients with carcinomas of the paranasal sinuses: clinical benefit for complex shaped target volumes. Radiat Oncol. 2006;21:1-23.
49. Kasperts N, Slotman BJ, Leemans CR et al. A review of re-irradiation for recurrent and second primary head and neck cancer. Oral Oncol. 2005;41: 224-243.
50. Lu TX, Mai WY, Teh BS, et al. Initial experience using intensity-modulated radiotherapy for recurrent nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys. 2004;58:682-687.
51. Chua DT, Sham JS, Au GK. Induction chemotherapy with cisplatin and gem-citabine followed by reirradiation for locally recurrent nasopharyngeal carcinoma. Am J Clin Oncol. 2005;28:464-471.
52. Gregoire V, Levendag P, Ang KK, et al. CT-based delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol. 2003;69: 227-236.
53. Hall EJ, Wuu CS. Radiation-induced second cancers: the impact of 3D-CRT and IMRT. Int J Radiat Oncol Biol Phys. 2003;56:83-88.
54. Eisbruch A, Lyden T, Bradford CR, et al. Objective assessment of dysphagia and aspiration following chemo-irradiation for head and neck cancer. Int J Radiat Oncol Biol Phys. 2002;53:23-28.
55. Eisbruch A, Schwartz M, Rasch C, et al. Dysphagia and aspiration after chemoradiotherapy for head and neck cancer: which anatomic structures are affected and can they be spared by IMRT? Int J Radiat Oncol Biol Phys. 2004; 60:1425-1439.
56. Feng FY, Lyden TH, Kim HM, et al. IMRT aimed at reducing dysphagia: early dose-volume-effect relationships for swallowing structures. Int J Radiat Oncol Biol Phys. 2006;66:S44-45.
57. Caglar H, Allen AM, Burke E, et al. Swallowing function after IMRT and chemotherapy for head and neck cancer. Proc Am Soc Clin Oncol. 2007. Abstract 6046.
58. Fua TF, Corry J, Milner AD, et al. Intensity-modulated radiotherapy for naso-pharyngeal carcinoma: clinical correlation of dose to the pharyngo-esophageal axis and dysphagia, Int J Radiat Oncol Biol Phys. 2007;67:976-981.